Johnson & Johnson Posts 3Q Earnings Growth as Sales Grow Across Divisions
October 19 2021 - 6:15AM
Dow Jones News
By Matt Grossman
Johnson & Johnson Tuesday logged a larger profit in its
third quarter, lifted by higher sales in its pharmaceutical,
medical-device and consumer-health divisions.
The New Brunswick, N.J.-based pharmaceutical company posted
earnings of $1.37 a share, up from $1.33 a share 12 months ago. Net
earnings were $3.67 billion, up from $3.55 billion a year
earlier.
Stripping out one-time items, the company's adjusted earnings
were $2.60 a share. Analysts polled by FactSet had been forecasting
adjusted earnings of $2.35 a share.
Sales rose 10.7% to $23.34 billion. Analysts were expecting
sales of $23.64 billion.
Pharmaceutical sales rose 13.8%, while medical-device sales were
7.6% higher year over year. Consumer-health sales increased by
5.7%. The segment sales trends exclude the effects of acquisitions
and divestitures.
Write to Matt Grossman at matt.grossman@wsj.com
(END) Dow Jones Newswires
October 19, 2021 07:00 ET (11:00 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
Johnson and Johnson (NYSE:JNJ)
Historical Stock Chart
From Apr 2024 to May 2024
Johnson and Johnson (NYSE:JNJ)
Historical Stock Chart
From May 2023 to May 2024